omega-n-methylarginine has been researched along with Cerebrovascular Moyamoya Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, M; Kajita, Y; Kimura, M; Mizutani, N; Seki, Y; Suzuki, Y; Takayasu, M | 1 |
1 other study(ies) available for omega-n-methylarginine and Cerebrovascular Moyamoya Disease
Article | Year |
---|---|
Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological conditions.
Topics: Animals; Antioxidants; Arginine; Arterioles; Cerebral Revascularization; Cerebrovascular Circulation; Collateral Circulation; Dose-Response Relationship, Drug; Humans; Male; Microcirculation; Moyamoya Disease; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasoconstrictor Agents; Vasomotor System | 2000 |